等待开盘 10-07 09:30:00 美东时间
-0.105
-0.60%
Zymeworks completes its Theravance Biopharma acquisition, boosts 2026 revenue guidance, and gains recurring revenue from YUPELRI sales.
09-29 01:05
Zymeworks Inc. (NASDAQ:ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced the final
09-28 18:12
https://www.fda.gov/news-events/press-announcements/fda-takes-step-forward-testosterone-therapy-men
04-16 23:37
Companies Reporting Before The Bell • Enovis (NYSE:ENOV) is estimated to report...
02-26 19:11
Companies Reporting Before The Bell • Clear Channel Outdoor (NYSE:CCO) is expec...
2025-11-06 19:12
Jefferies analyst Glen Santangelo maintains Viatris (NASDAQ:VTRS) with a Buy and lowers the price target from $15 to $13.
2025-03-08 01:17
本周一,美国股票市场迎来了特朗普政府新关税政策生效后的首个交易日,市场一度陷入恐慌性抛售,随后跌幅有所收窄。这种市场情绪可能预示着未来的波动格局,在此背景下,投...
2025-02-04 06:00
Regeneron filed an appeal after a court's decision, which was issued under seal.
2024-09-25 02:21
CC Lagator of Options AI warns traders to expect increased volatility in the week after September's 'triple witching,' with over $5 trillion in options expiring and historical evidence of market turbulence. VIX at 16 presents attractive opportunities for call option buyers.
2024-09-20 22:51
Increase in production of Takeda's ADHD drug Vyvanse, approved by DEA to address ongoing shortages both domestically and globally.
2024-09-06 21:46